Kate Collins

Research Scientist at the Nathan Kline Institute for Psychiatric Research and Assistant Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai

Papers

5 publications

Trials

0 clinical trials

Links

Key Impact

She is a clinical neuroscience researcher on ketamine trials and neuroimaging studies in PTSD and major depression, helping characterize rapid-acting antidepressant mechanisms.

Background & Research

Kate Collins, Ph.D., M.S.W., is a research scientist at the Nathan Kline Institute for Psychiatric Research and an Assistant Clinical Professor in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai. Her training spans social work and neuroscience, and her research focuses on clinical trials and functional MRI studies in mood and anxiety disorders, including ketamine-based interventions.

5

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

8 collaborators· click a node to visit their profile

Full network →